Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

Author

Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Executive Director

Title Created Date Category
Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH Friday, May 20, 2016 Scientific News
Abundance and Significance of Iron, Zinc, Copper, and Calcium in the Hearts of Patients With Friedreich Ataxia Thursday, May 19, 2016 Funded Research
Meeting Notice: FARA's Biomarker Meeting, Sept 16, 2016 Monday, May 9, 2016 Scientific News
Job Opportunity: Postdoctoral Fellow Position open at University of Alabama at Birmingham Thursday, May 5, 2016 Scientific News
Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation Thursday, May 5, 2016 Funded Research
Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) for the Treatment of People With Friedreich's Ataxia Thursday, May 5, 2016 Scientific News
Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia Monday, May 2, 2016 Scientific News
Time-resolved functional analysis of acute impairment of frataxin expression in an inducible cell model of Friedreich ataxia Tuesday, April 26, 2016 Scientific News
Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich ataxia Tuesday, April 19, 2016 Scientific News
Development of an AAV9 coding for a 3XFLAG-TALEfrat#8-VP64 able to increase in vivo the human frataxin in YG8R mice Monday, April 18, 2016 Scientific News

SHARE

FacebookTwitterLinkedInYoutube
Event D.jpg